10-Q: Morgan Stanley Soars in Q3 2025 with 45% Net Income Jump
Quarterly Report
Morgan Stanley reported robust third-quarter 2025 results, with net income surging 45% to $4.6 billion and diluted EPS rising 49% to $2.80, driven by strong performance across all business segments.
Summary
- Net revenues for Q3 2025 increased 18% to $18.2 billion, compared to $15.4 billion in Q3 2024.
- Net income applicable to Morgan Stanley rose 45% to $4.6 billion in Q3 2025, up from $3.2 billion in Q3 2024.
- Diluted earnings per common share increased 49% to $2.80 in Q3 2025, from $1.88 in Q3 2024.
- Return on Equity (ROE) was 18.0% and Return on Tangible Common Equity (ROTCE) was 23.5% for Q3 2025.
- The expense efficiency ratio improved to 67% for Q3 2025, down from 72% in Q3 2024.
- Institutional Securities net revenues grew 25% to $8.5 billion, driven by strong Equity performance and an Investment Banking rebound.
- Wealth Management net revenues increased 13% to $8.2 billion, with a pre-tax margin of 30.3%, adding $81 billion in net new assets.
- Investment Management net revenues rose 13% to $1.7 billion, primarily due to higher average Assets Under Management (AUM).
- The Provision for credit losses was $0 million in Q3 2025, reflecting macroeconomic improvements offsetting portfolio growth.
- The Stress Capital Buffer (SCB) was reduced from 5.1% to 4.3%, effective October 1, 2025, resulting in an aggregate Standardized Approach CET1 ratio of 11.8%.
- The Board reauthorized a multi-year common stock repurchase program of up to $20 billion, starting in Q3 2025.
- The quarterly common stock dividend was increased to $1.00 per share from $0.925, announced July 16, 2025.
Sentiment
Score: 9
Explanation: The filing reports exceptional financial performance with significant increases in net revenues, net income, and EPS, coupled with strong profitability metrics (ROE, ROTCE) that exceed internal goals. The improvement in the expense efficiency ratio and zero provision for credit losses are notable positives. Furthermore, the reduction in the SCB and the announcement of a substantial share repurchase program and increased dividend underscore robust capital management and confidence in the firm's outlook. While legal proceedings are ongoing, the overall financial health and strategic positioning are very strong.
Positives
- Significant growth in net revenues (18% for Q3, 16% YTD) and net income (45% for Q3, 29% YTD) and diluted EPS (49% for Q3, 31% YTD).
- Strong profitability metrics with ROE of 18.0% and ROTCE of 23.5% for Q3 2025, exceeding the firm's 20% ROTCE goal.
- Improved expense efficiency ratio of 67% for Q3 2025, demonstrating better cost management.
- Institutional Securities segment showed robust performance with 25% revenue growth and a 37% pre-tax margin.
- Wealth Management achieved a strong pre-tax margin of 30.3% and attracted $81 billion in net new assets.
- Investment Management also demonstrated solid growth with a 13% revenue increase.
- Zero provision for credit losses in Q3 2025, indicating a favorable macroeconomic outlook and effective risk management.
- Reduction in the Stress Capital Buffer (SCB) from 5.1% to 4.3%, effective October 1, 2025, which lowers capital requirements.
- Increased quarterly common stock dividend to $1.00 per share and a new $20 billion share repurchase authorization, signaling confidence in future performance and capital strength.
- Strong liquidity resources and compliance with Liquidity Coverage Ratio (LCR) and Net Stable Funding Ratio (NSFR) requirements.
- Positive market sentiment and increased capital markets activity in Q3 2025.
Negatives
- Compensation and benefits expenses increased 11% in Q3 2025 and YTD 2025, partly due to higher formulaic payouts and deferred compensation.
- Non-compensation expenses increased 9% in Q3 2025 and 10% YTD 2025, driven by execution-related expenses and technology spend.
- The Investment Management segment experienced continued net outflows in the Equity asset class, although offset by inflows in Alternatives and Solutions and Fixed Income.
- The decline in stock plan participants in the Workplace Channel due to the disposition of the EMEA stock plan business.
- Dutch criminal authorities served indictments on September 30, 2025, against Firm subsidiaries for filing false tax returns from 2007-2012, which the firm disputes.
- The plaintiff in the IKB International S.A. mortgage pass-through certificates case has appealed the dismissal of the case in the Firm's favor.
- Multiple putative class actions were filed against MSSB and E*TRADE Securities regarding cash sweep products, alleging failure to pay reasonable interest rates.
Risks
- Results of operations may be materially affected by competition.
- Legislative, legal, and regulatory developments could adversely impact strategic objectives.
- The rate of economic growth, ongoing geopolitical uncertainty, and central bank actions could impact capital markets and businesses.
- Geopolitical events and acts of war or aggression have potential adverse effects on future results.
- Non-trading market risk, particularly in Wealth Management, from lending and deposit-taking activities, is sensitive to interest rate changes.
- Credit risk refers to the risk of loss from borrowers, counterparties, or issuers failing to meet financial obligations.
- Operational risk includes the risk of loss or reputational damage from inadequate or failed processes, systems, human factors, or external events (e.g., cyberattacks).
- Model risk is the potential for adverse consequences from decisions based on incorrect or misused model outputs.
- Liquidity risk refers to the risk of being unable to finance operations due to loss of capital market access or difficulty liquidating assets, or inability to meet financial obligations without significant business disruption or reputational damage.
- Legal, regulatory, and compliance risk includes the risk of sanctions, material financial loss, business limitations, or reputational harm from non-compliance with laws and regulations.
- Climate risk consists of physical and transition risks, though not expected to have a significant near-term effect on consolidated results.
- A credit rating downgrade could lead to requirements for additional collateral or terminating payments, impacting liquidity and business.
- Wealth Management net interest income sensitivity is impacted by interest rate changes, client preferences for higher-yielding products, and loan demand.
- Investment Management asset management revenue sensitivity is dependent on market levels, asset class mix, price volatility, and client behavior.
Future Outlook
The firm's ROTCE goal is 20%, which it exceeded in Q3 2025. The rate of economic growth, ongoing geopolitical uncertainty, and central bank actions could continue to impact capital markets and businesses. The disposition of the EMEA stock plan business is expected to complete in the fourth quarter of 2025. Net interest income may be impacted in future periods by interest rate changes, client preferences, and central bank actions. Asset management revenue could continue to be impacted by market levels, AUM mix, and client preferences, including net outflows in the Equity asset class. The firm will provide updated information on applicable regulatory capital standards in response to a final rulemaking regarding proposed changes to capital requirements.
Management Comments
- "The Firm reported net revenues of $18.2 billion and net income applicable to Morgan Stanley of $4.6 billion reflecting strong results across business segments and regions."
- "The Firm delivered ROE of 18.0% and ROTCE of 23.5%."
- "Institutional Securities reported net revenues of $8.5 billion reflecting strong performance in Equity on higher client activity and a rebound in Investment Banking."
- "Wealth Management delivered a pre-tax margin of 30.3%. Net revenues of $8.2 billion reflect higher Asset management and Transactional revenues and higher Net interest income. The business added net new assets of $81 billion and fee-based asset flows were $42 billion."
- "Investment Management results reflect net revenues of $1.7 billion, primarily driven by asset management fees on higher average AUM."
- "We have an ROTCE goal of 20%."
- "We believe that accessing debt investors through multiple distribution channels helps provide consistent access to the unsecured markets."
- "The Firm disputes these charges [Dutch criminal indictments] and will continue to engage with the Prosecutor as the criminal process progresses."
Industry Context
The quarter was characterized by increased momentum in capital markets activity and lower interest rates, which generally benefits investment banking and trading businesses. The improvement in client and investor confidence and market sentiment aligns with a more constructive environment for financial services firms. Competition for deposits from other institutions and alternative cash-equivalent products is impacting net interest income, a common trend in a dynamic interest rate environment. The ongoing regulatory scrutiny and proposed changes to capital requirements (SCB, eSLR, stress testing) reflect a broader industry trend of increased oversight for large financial institutions.
Comparison to Industry Standards
- The ROTCE of 23.5% for Q3 2025 significantly exceeds the firm's stated internal goal of 20%, indicating strong performance relative to its own strategic benchmarks.
- The reduction in the Stress Capital Buffer (SCB) from 5.1% to 4.3% (effective October 1, 2025) is a positive regulatory outcome, potentially placing Morgan Stanley in a more favorable capital position compared to peers with higher SCBs, although specific peer comparisons are not provided in the filing.
- The firm's Standardized Common Equity Tier 1 capital ratio of 15.1% and Supplementary Leverage Ratio (SLR) of 5.5% demonstrate strong capital adequacy, generally above regulatory minimums and competitive within the Global Systemically Important Bank (G-SIB) landscape.
Legal Proceedings
- Interest Rate Swaps Antitrust Litigation: Settlement agreement reached, final approval granted July 17, 2025.
- VRDO Antitrust Litigation: Class certification affirmed August 1, 2025, seeking treble damages.
- Dutch Tax Authority (Civil): Settled for tax years 2007-2012 on November 11, 2024.
- Dutch Criminal Authorities (Tax): Indictments served September 30, 2025, against Firm subsidiaries for filing false tax returns (2007-2012); Firm disputes charges.
- U.K. Government Bond Matter: Settlement with U.K. CMA on February 21, 2025; U.S. class action settlement in principle October 2024, preliminary approval March 17, 2025.
- Camelot Event Driven Fund (Viacom/Archegos): Settlement agreement reached, final approval granted August 5, 2025.
- IKB International S.A. (Mortgage Pass-Through Certificates): Case dismissed in Firm's favor August 28, 2024; plaintiff has appealed.
- Cash Sweep Products Class Actions: Multiple putative class actions filed February 2024 against MSSB and E*TRADE Securities alleging failure to pay reasonable interest rates; MSSB moved to dismiss amended complaint on September 12, 2025. State securities regulators also requesting information.
Related Party Transactions
- Series C preferred stock is held by Mitsubishi UFJ Financial Group, Inc. (MUFG).
- Income from investment in Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (MUMSS) was $34 million for Q3 2025 and $100 million YTD 2025.
Stakeholder Impact
- Shareholders: Positive impact due to increased dividends, significant share repurchase program, strong earnings growth, and improved profitability metrics (ROE, ROTCE).
- Employees: Higher compensation and benefits expenses, partly due to formulaic payouts to Wealth Management advisors. Severance costs of $144 million recognized YTD 2025 due to a reduction in force.
- Customers: Wealth Management clients benefited from higher Asset management and Transactional revenues, and the business added substantial net new assets.
- Regulatory Bodies: Firm is actively engaging with regulators on proposed changes to capital requirements and stress testing frameworks, and is compliant with existing LCR and NSFR rules.
- Creditors: Strong capital ratios (CET1, SLR) and compliance with Total Loss-Absorbing Capacity (TLAC) requirements indicate robust financial health, reducing credit risk for lenders.
Next Steps
- Completion of the disposition of the EMEA stock plan business in Q4 2025.
- Continued engagement with the Dutch Public Prosecutor regarding the criminal indictments.
- Monitoring developments related to proposed revisions to SCB, CCAR, and eSLR frameworks.
- Plaintiff's appeal in the IKB International S.A. mortgage pass-through certificates case.
- MSSB and E*TRADE Securities will continue to respond to class actions regarding cash sweep products and state securities regulators' requests.
Key Dates
| Date | Description |
|---|---|
| December 15, 2023 | Court denied class plaintiffs' motion for class certification in the Interest Rate Swaps Antitrust Litigation. |
| December 29, 2023 | Class plaintiffs petitioned the United States Court of Appeals for the Second Circuit for leave to appeal the class certification decision in the Interest Rate Swaps Antitrust Litigation. |
| August 27, 2024 | Plaintiff in IKB International S.A. v. Morgan Stanley, et al. notified the court that it could not prove its claims at trial and requested dismissal. |
| August 28, 2024 | Court dismissed the IKB International S.A. v. Morgan Stanley, et al. case, with judgment entered in the Firm's favor; plaintiff has appealed. |
| September 16, 2024 | Court granted defendants' joint motion to dismiss the U.S. class action in the U.K. Government Bond Matter without prejudice. |
| October 2024 | The Firm and certain other defendants reached an agreement in principle to settle the U.S. litigation in the U.K. Government Bond Matter. |
| November 11, 2024 | The Firm reached an agreement to settle the Dutch Tax Authority's challenges for the tax years 2007 to 2012. |
| February 2024 | Multiple putative class actions were filed against Morgan Stanley Smith Barney LLC (MSSB) and E*TRADE Securities LLC (E*TRADE Securities) regarding cash sweep products. |
| February 21, 2025 | The U.K. Competition and Markets Authority announced a settlement with the Firm regarding suspected anti-competitive arrangements in the financial services sector. |
| February 28, 2024 | The parties reached an agreement in principle to settle the class claims in the Interest Rate Swaps Antitrust Litigation. |
| March 17, 2025 | Court granted preliminary approval of the settlement in the U.K. Government Bond Matter U.S. litigation. |
| April 3, 2025 | Court granted preliminary approval of the settlement in the Camelot Event Driven Fund (Viacom/Archegos) litigation. |
| April 7, 2025 | The Firm submitted its capital plan and company-run stress test results to the Federal Reserve. |
| April 17, 2025 | The Federal Reserve proposed revisions to the Stress Capital Buffer (SCB) and Comprehensive Capital Analysis and Review (CCAR) frameworks. |
| June 25, 2025 | The U.S. banking agencies released a proposal to modify enhanced Supplementary Leverage Ratio (eSLR) requirements. |
| June 30, 2025 | The Firm submitted its 2025 targeted resolution plan. |
| July 1, 2025 | The Board of Directors reauthorized a multi-year repurchase program of up to $20 billion of outstanding common stock. |
| July 16, 2025 | The Firm announced an increase in its quarterly common stock dividend to $1.00 per share from $0.925. |
| July 17, 2025 | Court granted final approval of the settlement in the Interest Rate Swaps Antitrust Litigation. |
| August 1, 2025 | The United States Court of Appeals for the Second Circuit affirmed the class certification decision in the Variable Rate Demand Obligations (VRDO) Antitrust Litigation. |
| August 5, 2025 | Court granted final approval of the settlement in the Camelot Event Driven Fund (Viacom/Archegos) litigation. |
| August 15, 2025 | An amended class action complaint was filed in the Estate of Sherlip, et al. v. Morgan Stanley, et al. (Cash Sweep Products). |
| September 12, 2025 | MSSB moved to dismiss the complaint in the Estate of Sherlip, et al. v. Morgan Stanley, et al. (Cash Sweep Products). |
| September 30, 2025 | End of the quarterly period covered by this report. |
| September 30, 2025 | The Federal Reserve announced a reduction in Morgan Stanley's SCB from 5.1% to 4.3%. |
| September 30, 2025 | The Dutch Public Prosecutor served indictments to Firm subsidiaries (Morgan Stanley Derivatives Products (Netherlands) B.V. and Morgan Stanley & Co. International plc) for filing false tax returns for 2007 to 2012. |
| October 1, 2025 | The reduced SCB of 4.3% became effective. |
| October 15, 2025 | Announcement date for the common stock dividend of $1.00 per share. |
| October 24, 2025 | The Federal Reserve proposed revisions to its supervisory stress testing framework. |
| October 31, 2025 | Record date for common stock dividend. |
| November 3, 2025 | Date of this Quarterly Report on Form 10-Q. |
| November 14, 2025 | Date the common stock dividend is to be paid. |
Recommendation
strong buyThe filing demonstrates exceptional financial performance with substantial year-over-year growth in net revenues, net income, and diluted EPS. Key profitability metrics like ROE and ROTCE are robust and exceed the firm's internal targets. The significant capital return to shareholders through an increased dividend and a large share repurchase authorization signals strong management confidence and capital adequacy. Furthermore, the reduction in the Stress Capital Buffer is a favorable regulatory development. While some legal challenges persist, the overall financial health, strategic execution across segments, and positive market conditions make Morgan Stanley a compelling investment opportunity.
Keywords
Morgan Stanley, Financial Services, Investment Banking, Wealth Management, Investment Management, SEC Filing, 10-Q, Earnings, Net Income, EPS, ROE, ROTCE, Capital Markets, Asset Management, Credit Risk, Regulatory Capital, Stress Capital Buffer, Share Repurchase, Dividends, Legal Proceedings, Antitrust, Tax Litigation, Derivatives, Liquidity, Market Risk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.